Gene patents in the primary prevention of vascular diseases

Gergely Feher, Zsolt Illes

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Atherosclerosis is the leading cause of death and disability in the developed world. Despite the use of aggressive therapies, a high morbidity and mortality with vascular origin persists. It is necessary to find new therapeutic targets complementing the existing ones to solve this sanitary problem. Basic and clinical investigation into many of the diverse aspects of cardiovascular drug discovery employs varied approaches aimed at determining physiologic and pathophysiologic efficacy of candidate agents for therapeutic utility with the ultimate hope of identifying those agents capable of exerting salutary influence upon cardiac and vascular tissues. We collected the articles published based on gene patenting in the primary prevention of vascular diseases. Promising compounds may then be used for prophylactic cardiovascular protection and for the treatment of various disorders including endothelial dysfunction, inflammation, hypertension and dyslipidaemia.

Original languageEnglish
Pages (from-to)164-171
Number of pages8
JournalRecent Patents on DNA and Gene Sequences
Volume2
Issue number3
Publication statusPublished - 2008

Fingerprint

Patents
Primary Prevention
Vascular Diseases
Blood Vessels
Genes
Cardiovascular Agents
Drug Discovery
Dyslipidemias
Cause of Death
Atherosclerosis
Therapeutics
Hypertension
Inflammation
Morbidity
Mortality

Keywords

  • Atherosclerosis
  • Dyslipidaemia
  • Endothelial dysfunction
  • Gene patents
  • Hypertension
  • Vascular disease

ASJC Scopus subject areas

  • Molecular Biology
  • Biotechnology
  • Genetics(clinical)

Cite this

Gene patents in the primary prevention of vascular diseases. / Feher, Gergely; Illes, Zsolt.

In: Recent Patents on DNA and Gene Sequences, Vol. 2, No. 3, 2008, p. 164-171.

Research output: Contribution to journalArticle

@article{b203a3fc7cbe41ff83386f4a0cd124e7,
title = "Gene patents in the primary prevention of vascular diseases",
abstract = "Atherosclerosis is the leading cause of death and disability in the developed world. Despite the use of aggressive therapies, a high morbidity and mortality with vascular origin persists. It is necessary to find new therapeutic targets complementing the existing ones to solve this sanitary problem. Basic and clinical investigation into many of the diverse aspects of cardiovascular drug discovery employs varied approaches aimed at determining physiologic and pathophysiologic efficacy of candidate agents for therapeutic utility with the ultimate hope of identifying those agents capable of exerting salutary influence upon cardiac and vascular tissues. We collected the articles published based on gene patenting in the primary prevention of vascular diseases. Promising compounds may then be used for prophylactic cardiovascular protection and for the treatment of various disorders including endothelial dysfunction, inflammation, hypertension and dyslipidaemia.",
keywords = "Atherosclerosis, Dyslipidaemia, Endothelial dysfunction, Gene patents, Hypertension, Vascular disease",
author = "Gergely Feher and Zsolt Illes",
year = "2008",
language = "English",
volume = "2",
pages = "164--171",
journal = "Recent patents on DNA & gene sequences",
issn = "2352-0922",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Gene patents in the primary prevention of vascular diseases

AU - Feher, Gergely

AU - Illes, Zsolt

PY - 2008

Y1 - 2008

N2 - Atherosclerosis is the leading cause of death and disability in the developed world. Despite the use of aggressive therapies, a high morbidity and mortality with vascular origin persists. It is necessary to find new therapeutic targets complementing the existing ones to solve this sanitary problem. Basic and clinical investigation into many of the diverse aspects of cardiovascular drug discovery employs varied approaches aimed at determining physiologic and pathophysiologic efficacy of candidate agents for therapeutic utility with the ultimate hope of identifying those agents capable of exerting salutary influence upon cardiac and vascular tissues. We collected the articles published based on gene patenting in the primary prevention of vascular diseases. Promising compounds may then be used for prophylactic cardiovascular protection and for the treatment of various disorders including endothelial dysfunction, inflammation, hypertension and dyslipidaemia.

AB - Atherosclerosis is the leading cause of death and disability in the developed world. Despite the use of aggressive therapies, a high morbidity and mortality with vascular origin persists. It is necessary to find new therapeutic targets complementing the existing ones to solve this sanitary problem. Basic and clinical investigation into many of the diverse aspects of cardiovascular drug discovery employs varied approaches aimed at determining physiologic and pathophysiologic efficacy of candidate agents for therapeutic utility with the ultimate hope of identifying those agents capable of exerting salutary influence upon cardiac and vascular tissues. We collected the articles published based on gene patenting in the primary prevention of vascular diseases. Promising compounds may then be used for prophylactic cardiovascular protection and for the treatment of various disorders including endothelial dysfunction, inflammation, hypertension and dyslipidaemia.

KW - Atherosclerosis

KW - Dyslipidaemia

KW - Endothelial dysfunction

KW - Gene patents

KW - Hypertension

KW - Vascular disease

UR - http://www.scopus.com/inward/record.url?scp=70350233326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350233326&partnerID=8YFLogxK

M3 - Article

C2 - 19075954

AN - SCOPUS:70350233326

VL - 2

SP - 164

EP - 171

JO - Recent patents on DNA & gene sequences

JF - Recent patents on DNA & gene sequences

SN - 2352-0922

IS - 3

ER -